Pulmonary Conditions & Tobacco Cessation Flashcards
What is pulmonary arterial htn?
-high BP in pulmonary artery (mPAP > 25)
-diagnosed with a right heart catheterization
–> imbalance of vasoconstrictor/vasodilators, imbalance of proliferation/apoptosis = enlarged right ventricle and right heart failure
Symptoms: fatigue, dyspnea, chest apin, syncope, edema, raynaud’s phenomenon
drugs that can cause PAH?
-cocaine and methamphetamines
-fenfluramine
-SSRI use during pregnancy (can inc risk of persistent pulmonary htn of a newborn)
-weight loss drugs (phentermine, diethylpropion, phendimetrazine)
Treatment of PAH
Non-drug: sodium restriction and immunizations
Drug:
-start: warfarin (INR 1.5-2.5) +/- diuretics +/- oxygen +/- Digoxin –> right heart cath and acute vasoactive testing =
+ : oral CCB (not verapamil)
- : begin a PAH approved drug
—> PDE-5 inhibitor
–> endothelin receptor antagonist
–> soluble guanylate cyclase stimulator
–> prostacyclin analogue
Prostacyclin analogues & receptor agonists for PAH
–> potent vasodilators (pulmonary and systemic) and platelet inhibitors
- Epoprostenol (Flolan) - ~ 5 min 1/2 life, PROTECT FROM LIGHT, ice pack for stability
- Trepostinil
- IIoprost (Ventavisa)
-Selexipag (Uptravi)
SEs: vasodilatroy, GI, anxiety, chest pain/palps, edema, jaw pain, neuropathy, site pain w. SC treprostiril, cought w/ inhaled products
**life-threatening is stopped suddenly!
Endothelin Receptor Antagonists (ERAs) for PAH
–> blocks endothelin, a vasoconstrictor with proliferative effects
- Bosentan (Tracleer)
- Ambrisentan (Letairis)
- Macitentan (Opsumit)
BBW: restricted access programs: embryo-fetal toxicity, Bosentan: hepatotoxicity
SEs: headahce, edema, hypotension, flushing
Phosphodiesterase-5 (PDE-5) Inhibitors for PAH
–> cause pulmonary vasculature relaxation and vasodilation
-Sildenafil (Revatio): 20 mg TID, taken 4-6 hhrs apart, avoid use for PAH in pts taking PI-based regimens
-Tadalafil (Adcira): 40 mg daily, avoid if crcl < 30
SE: dizziness, hypotension, headache
CI w/ nitrates
Soluble Guanglate Cyclase (sCG) stimulator for PAH
-Riocigulat (Adempas)
- used for group 1 and group 4
–> lots of drug interactions!
Select drugs that can cause pulmonary fibrosis*
-Amiodarone/dronedarone
-Bleomycin
-Busulfan
-Carmustine
-Lomustine
-Nitrofurantoin
-Sulfalazine
Pulmonary Fibrosis
-presents as exertional dyspnea with nonproductive cough
Drugs that tx: pirfenidone (Esbriet) and nontedanib (Ofev) –> slow the rate of lung function decline
Diagnosis and assessment of Asthma
via spirometry
-FEV1: how much air can be forcefully exhaled in 1 second
-FVC: the max volume of air that is exhaled after taking a deep breath
-FEV1/FVC: the percentage of total air capacity (vital capacity) that can be forcefully exhaled in 1 sec
Criteria: measure FEV1 –> give bronchodilator –> measure FEV1 –> inc FEV1 > 12% = reversibility/diagnosis
Initial asthma assessment (symptom frequency per step & rescue inhaler use)
Step 1:
–> < 2 times per month daytime
–> no nighttime
- < 2 days/week
Step 2:
–> > 2x/month daytime
–> < 4-5 days/day nighttime
- > 2 days/week but not daily or >1 x/day
Step 3:
–> most days
–> >1 x/week nighttime
-daily
Steps 4&5:
–> daily
–> > 1x/week nighttime
-several times per day
Asthma Treatment Algorithm: step 1
-symptoms < 2x/month
–> PRN low dose ICS + formoterol
OR
–> low dose ICS + SABA
Asthma Treatment Algorithm: step 2
-symptoms/need for SABA 2x/month
–> low dose ISC daily
OR
–> low dose ICS + SABA
Asthma Treatment Algorithm: Step 3
-symptoms on most days or waking at night >1 x/week
–> low dose ISC + LABA
Asthma Treatment Algorithm: Step 4
-daily symptoms, waking at night > 1x/week
–> medium dose ICS + LABA
Asthma Treatment Algorithm: step 5
-severe persistent
–> high. dose ICS + LABA
-refer for assessment
Beta 2 agonists: SABAs
–> albuterol, levalbuterol
-PRN use only, not rec to use SABA alone
-200 inhalations/canister
-ProAir RespiClick: dry powder formulation
-Primatene Mist- OTC epinephrine
SEs: nervousness/tremor, tachycardia, palpitations, cough, inc BG, dec K
Controller/Maintenance Inhalers for asthma: ICS
–> Beclomethasone (QVAR RediHaler)
–> Budesonide (Pulmocort Flexhaler)
–> Fluticasone (Flovant HFA, Flovant Discus, Arnuity Ellipta)
Beta-2 Agonists: LABAs
–> salmeterol, formoterol
BBW: inc risk of asthma related death when used as monotherapy
-only use as add on to ICS therapy
-formoterol used for rescue WITH ICS
SEs: nervousness/tremor, tachycardia, palpitations, cough, inc BG, dec K
Inhaled corticosteroids for asthma
–> 1st line tx for persistant asthma for all pts, even children
-used PRN w/ fomoterol or SABA for rescue
Warnings: adrenal suppression w/ prolonged use of high doses = growth retardation in children
SEs: dysphonia, oral candidiasis (thrush), cough, inc BG
-Beclomethasone (QVAR RediHaler)
-Budesonide (Pulmicort Flexhaler)
-Fluticasone (Flovant HFA)
Controller/Maintenance Inhalers for COPD: ICS
there is no single ICS product that is FDA approved for COPD
Controller/Maintenance Inhalers for asthma: LABA
Salmeterol (Serevent discus)
Controller/Maintenance Inhalers for COPD: LABA
-Salmetrol (servent discus)
-Formoterol (Performomist - neb)
-Arfomoterol (Brovana - neb)
-Olodaterol (Striverdi Respimet)
Controller/Maintenance Inhalers for asthma: LAMA
Tiotropium (Spirivia Respimet)
Controller/Maintenance Inhalers for COPD: LAMA
-Tiotropium (Spiriva HandiHaler, Spiriva Respimet)
-Adidinium (Tudorza Pressair)
-Glycopyrrolate (Lonhala magnair- neb)
-Revefenacin *Yuperli-neb)
-Umeclidinium (Incruse Ellipta)
Controller/Maintenance Inhalers for asthma: ICS/LABA
-Budesonide/formoterol (Symbicort)
-Fluticasone/salmeterol (Advair Discus, Advair HFA)
-Mometasone/formoterol (Dulera)
-Fluticasone/Vilanterol. (Breo Ellipta)
Controller/Maintenance Inhalers for COPD: ISC/LABA
-Budesonide/formoterol (Symbicort)
-Fluticasone/salmetrol (Advair Diskus)
-Fluuticasone/vilanterol (Brea Ellipta)
Controller/Maintenance Inhalers for asthma: LABA/LAMA
-none are FDA approved